login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIOVENTUS INC - A (BVS) Stock News
USA
- NASDAQ:BVS -
US09075A1088
-
Common Stock
7.48
USD
+0.03 (+0.4%)
Last: 11/10/2025, 9:51:59 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BVS Latest News, Press Relases and Analysis
All
Press Releases
6 days ago - By: Chartmill
- Mentions:
TGE
PAY
FORD
HTZ
...
These stocks are gapping in today's session
6 days ago - By: Chartmill
Bioventus Inc (NASDAQ:BVS) Reports Q3 2025 Earnings Beat and Strong Profitability Growth
6 days ago - By: Bioventus, Inc.
Bioventus Reports Third Quarter Financial Results
6 days ago - By: Bioventus, Inc.
Bioventus Reports Third Quarter Financial Results
6 days ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
13 days ago - By: Bioventus, Inc.
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
13 days ago - By: Bioventus, Inc.
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025
19 days ago - By: Halper Sadeh LLC
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
2 months ago - By: Bioventus, Inc.
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
2 months ago - By: Bioventus, Inc.
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
3 months ago - By: Yahoo Finance
Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT
3 months ago - By: Bioventus, Inc.
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
3 months ago - By: Bioventus, Inc.
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
3 months ago - By: Zacks Investment Research
- Mentions:
CASI
Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates
3 months ago - By: Bioventus, Inc.
Bioventus Reports Second Quarter Financial Results
3 months ago - By: Bioventus, Inc.
Bioventus Reports Second Quarter Financial Results
3 months ago - By: Benzinga
- Mentions:
OEC
VTLE
DIN
INSE
...
Earnings Scheduled For August 6, 2025
3 months ago - By: Bioventus, Inc.
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
3 months ago - By: Bioventus, Inc.
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
3 months ago - By: Bioventus, Inc.
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
3 months ago - By: Bioventus, Inc.
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products
3 months ago - By: Bioventus, Inc.
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
3 months ago - By: Bioventus, Inc.
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
4 months ago - By: Yahoo Finance
Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating
6 months ago - By: Zacks Investment Research
- Mentions:
NOTV
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates
6 months ago - By: Bioventus, Inc.
Bioventus Reports First Quarter Financial Results
6 months ago - By: Bioventus, Inc.
Bioventus Reports First Quarter Financial Results
7 months ago - By: Bioventus, Inc.
Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
7 months ago - By: Zacks Investment Research
- Mentions:
RIGL
FOLD
ENSG
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
7 months ago - By: Zacks Investment Research
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now
8 months ago - By: Bioventus, Inc.
Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
Please enable JavaScript to continue using this application.